These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering. Pedersen TR Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729 [TBL] [Abstract][Full Text] [Related]
4. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study. Strandberg TE; Feely J; Sigurdsson EL; Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694 [TBL] [Abstract][Full Text] [Related]
5. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly. Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195 [TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin: a review of its use in the prevention of cardiovascular disease in apparently healthy women or men with normal LDL-C levels and elevated hsCRP levels. Carter NJ Am J Cardiovasc Drugs; 2010; 10(6):383-400. PubMed ID: 21090831 [TBL] [Abstract][Full Text] [Related]
7. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. Cannon CP; Braunwald E; McCabe CH; Rader DJ; Rouleau JL; Belder R; Joyal SV; Hill KA; Pfeffer MA; Skene AM; N Engl J Med; 2004 Apr; 350(15):1495-504. PubMed ID: 15007110 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of statin therapy in adults with coronary heart disease. Wilt TJ; Bloomfield HE; MacDonald R; Nelson D; Rutks I; Ho M; Larsen G; McCall A; Pineros S; Sales A Arch Intern Med; 2004 Jul; 164(13):1427-36. PubMed ID: 15249352 [TBL] [Abstract][Full Text] [Related]
9. Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks. McKenney JM Am J Cardiol; 2005 Aug; 96(4A):60E-66E. PubMed ID: 16098846 [TBL] [Abstract][Full Text] [Related]
10. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study. Zhao SP; Peng DQ; Yu BL; Huo Y; Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407 [TBL] [Abstract][Full Text] [Related]
11. Attainment of optional low-density lipoprotein cholesterol goal of less than 70 mg/dl and impact on prognosis of very high risk stable coronary patients: a 3-year follow-up. Rallidis LS; Kotakos C; Sourides V; Varounis C; Charalampopoulos A; Zolindaki M; Dagres N; Papadopoulos C; Anastasiou-Nana M Expert Opin Pharmacother; 2011 Jul; 12(10):1481-9. PubMed ID: 21651448 [TBL] [Abstract][Full Text] [Related]
12. Statins and stroke prevention. Paciaroni M; Hennerici M; Agnelli G; Bogousslavsky J Cerebrovasc Dis; 2007; 24(2-3):170-82. PubMed ID: 17596685 [TBL] [Abstract][Full Text] [Related]
13. Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. Nissen SE Am J Cardiol; 2005 Sep; 96(5A):61F-68F. PubMed ID: 16126025 [TBL] [Abstract][Full Text] [Related]
14. Concordance between plasma apolipoprotein B levels and cholesterol indices among patients receiving statins and nonstatin treatment: Post-hoc analyses from the U.K. InPractice study. Idris I; Tate H; Ahmad A; McCormack T J Clin Lipidol; 2011; 5(4):316-23. PubMed ID: 21784378 [TBL] [Abstract][Full Text] [Related]
15. Lipid-lowering therapy and the patient with multiple risk factors: what have we learned from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)? Sever PS Am J Med; 2005 Dec; 118 Suppl 12A():3-9. PubMed ID: 16356801 [TBL] [Abstract][Full Text] [Related]
16. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study. Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A; Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888 [TBL] [Abstract][Full Text] [Related]
17. Statins and LDL-cholesterol lowering: an overview. Stroes E Curr Med Res Opin; 2005; 21 Suppl 6():S9-16. PubMed ID: 16138936 [TBL] [Abstract][Full Text] [Related]
18. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy. Wiviott SD; Cannon CP Curr Opin Lipidol; 2006 Dec; 17(6):626-30. PubMed ID: 17095906 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study. Koren MJ; Hunninghake DB; J Am Coll Cardiol; 2004 Nov; 44(9):1772-9. PubMed ID: 15519006 [TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]